62
Participants
Start Date
February 28, 2010
Primary Completion Date
July 31, 2010
Study Completion Date
July 31, 2010
AZD1446
ER Fast, 90mg, p.o. capsule
AZD1446
ER Moderate, 90mg, p.o. capsule
AZD1446
ER Slow, 90mg, p.o. capsule
AZD1446
MR
AZD1446
IR, 90 mg p.o. capsule
Placebo
IR
Placebo
ER/MR
Research Site, Luleå
Research Site, Uppsala
Lead Sponsor
AstraZeneca
INDUSTRY